General MedicationsINJECTIONStandard

PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER

CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE

Standard Dose

N/A/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;6.95GM/1000ML;0.187GM/1000ML (5000ML)

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER is listed in Drugs@FDA under application 207026 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE Form and strength INJECTABLE;INJECTION - N/A/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;6.95GM/1000ML;0.187GM/1000ML (5000ML) Sponsor VANTIVE US HLTHCARE Submission history Latest submission status date: 2023-05-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER is listed in Drugs@FDA under application 207026 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE Form and strength INJECTABLE;INJECTION - N/A/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;6.95GM/1000ML;0.187GM/1000ML (5000ML) Sponsor VANTIVE US HLTHCARE Submission history Latest submission status date: 2023-05-02 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.